Randomised controlled trials

New Course on Randomised Clinical Trials

The George Institute for Global Health is launching a new course, Introduction to Randomised Clinical Trials (RCTs), to build capacity and strengthen evidence-based approaches to global health challenges.

RCTs are considered to produce the highest quality of evidence on the effects of interventions because of their ability to minimise bias. Critical to successful generation of high-quality evidence through RCTs is the knowledge and skills to properly design, conduct, analyse and report them.

“RCTs are extremely important in medical research and we’re very proud to be offering this course to equip the next generation of researchers with the knowledge and tools they need to contribute to future advances in global health” - Helen Monaghan, Director, Global Project Operations, Centre for Operational and Research Excellence, The George Institute, Australia

The 12 to 13 week online course beginning on 07 June 2022 will be delivered by experienced researchers and trial managers at The George Institute. It will provide early career researchers (The George Institute staff, consultants, students, visiting fellows, collaborators, and partners) with a comprehensive introduction to the fundamentals of RCTs, including effective trial management.

This course will harness the knowledge gained and skills developed over more than 20 years of ground-breaking RCTs carried out at The George Institute. After completing this course, participants will have understanding of the strengths and limitations of RCTS and how they can be applied to have real world impact and improve people’s health.” - Niveditha Devasenapathy, Lead, Better Treatments, The George Institute, India


Abdul Salam
The George Institute for Global Health

Kate Ballard
The George Institute for Global Health